Teligent, Inc. TLGTQ OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

25/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Teligent, Inc. (TLGTQ) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 24/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

25/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✓

健康

100/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

0/100

→ Income

✗

成长

15/100

→ Income

✗

收入

10/100

→ Income

估值概览 — TLGTQ

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-14.67

每股账面价值$0.00

每股营收$5.45

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2011	$-0.76	$7.81M	$-3.01M	-38.5%
2012	$-0.99	$8.56M	$-3.93M	-45.9%
2013	$-0.02	$18.22M	$-84K	-0.5%
2014	$0.82	$33.74M	$5.25M	15.6%
2015	$0.99	$44.25M	$6.67M	15.1%
2016	$-2.26	$66.88M	$-11.99M	-17.9%
2017	$-2.85	$67.25M	$-15.19M	-22.6%
2018	$-6.77	$65.87M	$-36.26M	-55%
2019	$-4.67	$65.9M	$-25.12M	-38.1%
2020	$-14.67	$45.31M	$-122.02M	-269.3%